These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cayman
Islands
|
|
98-1150254
|
|
(State
or other jurisdiction of incorporation or
organization)
|
|
(I.R.S.
Employer Identification No.)
|
|
Suite
20142 Edward Street, Georgetown
P.O.
Box 469
Grand
Cayman, Cayman Islands
|
|
KY1-9006
|
|
(Address
of principal executive offices)
|
|
(Zip
Code)
|
|
Large
accelerated filer ☐
|
|
Accelerated
filer ☐
|
|
Non-accelerated
filer ☐
|
|
Smaller
reporting company ☒
|
|
Emerging growth
company ☐
|
|
|
|
PART I – FINANCIAL INFORMATION
|
Page
|
|
|
|
|
3
|
|
|
|
|
|
3
|
|
|
|
|
|
4
|
|
|
|
|
|
5
|
|
|
|
|
|
6
|
|
|
|
|
|
8
|
|
|
|
|
|
9
|
|
|
|
|
|
29
|
|
|
|
|
|
38
|
|
|
|
|
|
38
|
|
|
|
|
|
PART II – OTHER INFORMATION
|
|
|
|
|
|
39
|
|
|
|
|
|
39
|
|
|
|
|
|
39
|
|
|
|
|
|
39
|
|
|
|
|
|
39
|
|
|
|
|
|
39
|
|
|
|
|
|
40
|
|
|
|
|
|
41
|
|
|
At March 31,
2020
|
At December 31,
2019
|
|
|
(Unaudited)
|
|
|
Assets
|
|
|
|
Investments:
|
|
|
|
Equity securities,
at fair value (cost: $1,321 and $715, respectively)
|
$
972
|
692
|
|
Cash
and cash equivalents
|
5,068
|
5,962
|
|
Restricted
cash and cash equivalents
|
2,343
|
2,054
|
|
Accrued
interest and dividend receivable
|
4
|
12
|
|
Premiums
receivable
|
227
|
506
|
|
Deferred
policy acquisition costs
|
19
|
48
|
|
Operating
lease right-of-use asset
|
284
|
133
|
|
Prepayment
and other assets
|
123
|
79
|
|
Property
and equipment, net
|
8
|
9
|
|
Total
assets
|
$
9,048
|
9,495
|
|
|
|
|
|
Liabilities and Shareholders’ Equity
|
|
|
|
Liabilities:
|
|
|
|
Notes
payable to noteholders
|
$
600
|
600
|
|
Unearned
premiums reserve
|
176
|
440
|
|
Operating
lease liabilities
|
284
|
133
|
|
Accounts
payable and other liabilities
|
301
|
279
|
|
Total
liabilities
|
1,361
|
1,452
|
|
|
|
|
|
Shareholders’
equity:
|
|
|
|
Ordinary
share capital, (par value $0.001, 50,000,000 shares authorized;
5,733,587 shares issued and outstanding)
|
6
|
6
|
|
Additional
paid-in capital
|
32,270
|
32,262
|
|
Accumulated
Deficit
|
(24,589
)
|
(24,225
)
|
|
Total
shareholders’ equity
|
7,687
|
8,043
|
|
Total
liabilities and shareholders’ equity
|
$
9,048
|
9,495
|
|
|
Three Months Ended
|
|
|
|
March 31,
|
|
|
|
2020
|
2019
|
|
Revenue
|
|
|
|
|
|
|
|
Net
premiums earned
|
$
264
|
-
|
|
Net
investment income
|
33
|
63
|
|
Net realized investment gains
|
6
|
3
|
|
Change in fair value of equity securities
|
(326
)
|
51
|
|
|
|
|
|
Total
revenue
|
(23
)
|
117
|
|
|
|
|
|
Expenses
|
|
|
|
Policy
acquisition costs and underwriting expenses
|
29
|
-
|
|
General
and administrative expenses
|
246
|
264
|
|
|
|
|
|
Total
expenses
|
275
|
264
|
|
|
|
|
|
Loss
before income attributable to noteholders
|
(298
)
|
(147
)
|
|
|
|
|
|
Income
attributable to noteholders
|
(66
)
|
-
|
|
|
|
|
|
Net
loss
|
$
(364
)
|
(147
)
|
|
|
|
|
|
|
|
|
|
Loss per share
|
|
|
|
Basic
and Diluted
|
$
(0.06
)
|
(0.03
)
|
|
|
|
|
|
Weighted-average shares outstanding
|
|
|
|
Basic
and Diluted
|
5,733,587
|
5,733,587
|
|
|
|
|
|
|
|
|
|
Dividends paid per share
|
$
-
|
-
|
|
|
Three Months Ended
|
|
|
|
March 31,
|
|
|
|
2020
|
2019
|
|
|
|
|
|
|
|
|
|
Net
loss
|
$
(364
)
|
(147
)
|
|
Other
comprehensive loss:
|
|
|
|
Change
in unrealized loss on investments:
|
|
|
|
Unrealized
gain arising during the period
|
-
|
1
|
|
Reclassification
adjustment for net realized investment gains included in net
loss
|
-
|
(3
)
|
|
|
|
|
|
Net
change in unrealized loss
|
-
|
(2
)
|
|
|
|
|
|
Total
other comprehensive loss
|
-
|
(2
)
|
|
|
|
|
|
Comprehensive
loss
|
$
(364
)
|
(149
)
|
|
|
Three Months Ended
|
|
|
|
March 31,
|
|
|
|
2020
|
2019
|
|
Operating activities
|
|
|
|
Net
loss
|
$
(364
)
|
(147
)
|
|
Adjustments
to reconcile net loss to net cash used in operating
activities:
|
|
|
|
Stock-based
compensation
|
8
|
9
|
|
Depreciation
and amortization
|
2
|
2
|
|
Net
realized investment gains
|
(6
)
|
(3
)
|
|
Change
in fair value of equity securities
|
326
|
(51
)
|
|
Change
in operating assets and liabilities:
|
|
|
|
Accrued
interest and dividend receivable
|
8
|
7
|
|
Premiums
receivable
|
279
|
-
|
|
Deferred
policy acquisition costs
|
29
|
-
|
|
Operating
leases right-of-use assets
|
-
|
(6
)
|
|
Prepayment
and other receivables
|
(44
)
|
(51
)
|
|
Reserve
for losses and loss adjustment expenses
|
-
|
(4,001
)
|
|
Unearned
premiums reserve
|
(264
)
|
-
|
|
Accounts
payable and other liabilities
|
22
|
(10
)
|
|
|
|
|
|
Net
cash used in operating activities
|
$
(4
)
|
(4,251
)
|
|
|
|
|
|
Investing activities
|
|
|
|
Purchase
of equity securities
|
(846
)
|
-
|
|
Proceeds
from sale of fixed-maturity and equity securities
|
246
|
994
|
|
Purchase
of property and equipment
|
(1
)
|
-
|
|
|
|
|
|
Net
cash (used in)/provided by investing activities
|
$
(601
)
|
994
|
|
|
(continued)
|
|
|
|
Three Months Ended
|
|
|
|
March 31,
|
|
|
|
2020
|
2019
|
|
|
|
|
|
Cash
and cash equivalents, and restricted cash and cash
equivalents:
|
|
|
|
Net
change during the period
|
(605
)
|
(3,257
)
|
|
Balance
at beginning of period
|
8,016
|
11,299
|
|
|
|
|
|
Balance
at end of period
|
$
7,411
|
8,042
|
|
|
|
|
|
Supplemental disclosure of cash flow information
|
|
|
|
Interest
paid
|
-
|
-
|
|
Income
taxes paid
|
-
|
-
|
|
|
|
|
|
Non-cash investing activities
|
|
|
|
Net
change in unrealized loss on securities available for
sale
|
-
|
(2
)
|
|
Operating
lease right-of-use assets
|
$
169
|
155
|
|
Operating
lease liability
|
$
169
|
149
|
|
|
|
|
|
|
Ordinary Share Capital
|
Additional Paid-in
|
Accumulated
|
Accumulated Other
Comprehensive Income
|
Total Shareholders'
|
|
|
|
Shares
|
Amount
|
Capital
|
Deficit
|
(Loss)
|
Equity
|
|
|
|
|
|
|
|
|
|
Balance
at December 31, 2018
|
5,733,587
|
6
|
32,226
|
(23,920
)
|
2
|
8,314
|
|
Net
loss for the period
|
-
|
-
|
-
|
(147
)
|
-
|
(147
)
|
|
Stock-based
compensation
|
-
|
-
|
9
|
-
|
-
|
9
|
|
Total
other comprehensive loss
|
-
|
-
|
-
|
-
|
(2
)
|
(2
)
|
|
Balance
at March 31, 2019
|
5,733,587
|
6
|
32,235
|
(24,067
)
|
-
|
8,174
|
|
|
|
|
|
|
|
|
|
Balance
at December 31, 2019
|
5,733,587
|
6
|
32,262
|
(24,225
)
|
-
|
8,043
|
|
Net
loss for the period
|
-
|
-
|
-
|
(364
)
|
-
|
(364
)
|
|
Stock-based
compensation
|
-
|
-
|
8
|
-
|
-
|
8
|
|
Balance
at March 31, 2020
|
5,733,587
|
6
|
32,270
|
(24,589
)
|
-
|
7,687
|
|
|
At March 31,
|
At December 31,
|
|
|
2020
|
2019
|
|
|
(in thousands)
|
|
|
|
|
|
|
Cash
on deposit
|
$
2,872
|
$
3,456
|
|
Cash
held with custodians
|
2,196
|
2,506
|
|
Restricted
cash held in trust
|
2,343
|
2,054
|
|
|
|
|
|
Total
|
$
7,411
|
$
8,016
|
|
|
Gross proceeds
from sales
|
Gross
Realized
Gains
|
Gross
Realized
Losses
|
|
|
($ in
thousands)
|
||
|
Three Months Ended March 31, 2020
|
|
|
|
|
Equity
securities
|
$
246
|
$
6
|
$
-
|
|
|
|
|
|
|
Three Months Ended March 31, 2019
|
|
|
|
|
Available-for-sale
fixed-maturity securities
|
$
994
|
$
3
|
$
-
|
|
|
Fair Value
Measurements Using
|
|
||
|
|
(Level
1)
|
(Level
2)
|
(Level
3)
|
Total
|
|
As of March 31, 2020
|
($ in thousands)
|
|||
|
Financial
Assets:
|
|
|
|
|
|
Cash and cash equivalents
|
$
5,068
|
$
-
|
$
-
|
$
5,068
|
|
|
|
|
|
|
|
Restricted cash and cash equivalents
|
$
2,343
|
$
-
|
$
-
|
$
2,343
|
|
|
|
|
|
|
|
Total equity
securities
|
972
|
-
|
-
|
972
|
|
|
|
|
|
|
|
Total
|
$
8,383
|
$
-
|
$
-
|
$
8,383
|
|
|
Fair Value
Measurements Using
|
|
||
|
|
(Level
1)
|
(Level
2)
|
(Level
3)
|
Total
|
|
As of December 31, 2019
|
($ in thousands)
|
|||
|
Financial
Assets:
|
|
|
|
|
|
Cash and cash equivalents
|
$
5,962
|
$
-
|
$
-
|
$
5,962
|
|
|
|
|
|
|
|
Restricted cash and cash equivalents
|
$
2,054
|
$
-
|
$
-
|
$
2,054
|
|
|
|
|
|
|
|
Total equity
securities
|
692
|
-
|
-
|
692
|
|
|
|
|
|
|
|
Total
|
$
8,708
|
$
-
|
$
-
|
$
8,708
|
|
|
At March 31,
|
At March 31,
|
|
|
2020
|
2019
|
|
|
(in thousands)
|
|
|
|
|
|
|
Balance,
beginning of period
|
$
-
|
$
4,108
|
|
Incurred
related to:
|
|
|
|
Current
period
|
-
|
-
|
|
Prior
period
|
-
|
-
|
|
Total
incurred
|
-
|
-
|
|
Paid
related to:
|
|
|
|
Current
period
|
-
|
-
|
|
Prior
period
|
-
|
(4,001
)
|
|
Total
paid
|
-
|
(4,001
)
|
|
Balance,
end of period
|
$
-
|
$
107
|
|
|
Three Months Ended
|
|
|
|
March 31,
|
|
|
|
2020
|
2019
|
|
Numerator:
|
|
|
|
Net
loss
|
$
(364
)
|
(147
)
|
|
|
|
|
|
Denominator:
|
|
|
|
Weighted
average shares - basic
|
5,733,587
|
5,733,587
|
|
Effect
of dilutive securities - Stock options
|
-
|
-
|
|
Shares
issuable upon conversion of warrants
|
-
|
-
|
|
Weighted
average shares - diluted
|
5,733,587
|
5,733,587
|
|
Loss
per share - basic
|
$
(0.06
)
|
(0.03
)
|
|
Loss
per share - diluted
|
$
(0.06
)
|
(0.03
)
|
|
|
|
|
|
|
Number
of
Options
|
Weighted-
Average
Exercise
Price
|
Weighted-
Average
Remaining
Contractual
Term
|
Aggregate
Intrinsic
Value
|
|
Outstanding
at January 1, 2020
|
540,000
|
|
|
|
|
Outstanding
at March 31, 2020
|
540,000
|
$
3.86
|
7.1 years
|
$
-
|
|
Exercisable
at March 31, 2020
|
334,063
|
$
4.92
|
6.2 years
|
$
-
|
|
Outstanding
at January 1, 2019
|
250,000
|
|
|
|
|
Granted
|
290,000
|
$
2.00
|
|
|
|
Outstanding
at March 31, 2019
|
540,000
|
$
3.86
|
8.1 years
|
$
-
|
|
Exercisable
at March 31, 2019
|
246,250
|
$
5.71
|
6.4 years
|
$
-
|
|
|
2019
|
|
|
|
|
Expected
dividend yield
|
0
%
|
|
Expected
volatility
|
31
%
|
|
Risk-free
interest rate
|
2.59
%
|
|
Expected
life (in years)
|
10
|
|
Per
share grant date fair value of options issued
|
$
0.36
|
|
|
For the Three-
Month Period
|
For the Three-
Month Period
|
|
(in thousands)
|
Ended
March 31,
2020
|
Ended
March 31,
2019
|
|
Operating Lease Cost
(1)
|
$
24
|
$
19
|
|
|
|
|
|
Cash
paid for amounts included in the measurement of lease
liabilities
|
|
|
|
Operating
cash flows from operating leases
|
$
24
|
$
33
|
|
|
|
|
|
(1)
Includes short-term
leases
|
|
|
|
(in thousands)
|
At March 31,
2020
|
At March 31,
2019
|
|
Operating
lease right-of-use assets
|
$
284
|
$
155
|
|
|
|
|
|
Operating
lease liabilities
|
$
284
|
$
149
|
|
|
|
|
|
Weighted-average
remaining lease term - operating leases
|
3.30 years
|
4.92 years
|
|
|
|
|
|
Weighted-average
discount rate - operating leases
|
5.25
%
|
6.5
%
|
|
(in thousands)
|
At March 31,
2020
|
At December 31,
2019
|
|
Remainder
of 2020
|
$
72
|
$
36
|
|
2021
|
96
|
36
|
|
2022
|
97
|
37
|
|
2023
|
40
|
37
|
|
Thereafter
|
6
|
6
|
|
Total
future minimum lease payments
|
$
311
|
$
152
|
|
|
|
|
|
Less
imputed interest
|
(27
)
|
(19
)
|
|
Total
operating lease liability
|
$
284
|
133
|
|
|
Three Months Ended
|
|
|
|
March 31,
|
|
|
|
2020
|
2019
|
|
Revenue
|
|
|
|
|
|
|
|
Net
premiums earned
|
264
|
-
|
|
Net
investment income
|
33
|
63
|
|
Net
realized investment gains
|
6
|
3
|
|
Change
in fair value of equity securities
|
(326
)
|
51
|
|
|
|
|
|
Total
revenue
|
(23
)
|
117
|
|
|
|
|
|
Expenses
|
|
|
|
Policy
acquisition costs and underwriting expenses
|
29
|
-
|
|
General
and administrative expenses
|
246
|
264
|
|
|
|
|
|
Total
expenses
|
275
|
264
|
|
|
|
|
|
Loss
before income loss attributable to noteholders
|
$
(298
)
|
(147
)
|
|
|
|
|
|
Income
attributable to noteholders
|
(66
)
|
-
|
|
|
|
|
|
Net
loss
|
$
(364
)
|
(147
)
|
|
|
|
|
|
Basic loss per share
|
$
(0.06
)
|
(0.03
)
|
|
|
|
|
|
Diluted loss per share
|
$
(0.06
)
|
(0.03
)
|
|
|
|
|
|
Weighted-average shares outstanding
|
|
|
|
Basic
and Diluted
|
5,733,587
|
5,733,587
|
|
|
|
|
|
Dividends paid per share
|
$
-
|
-
|
|
|
|
|
|
Performance
ratios to net premiums earned:
|
|
|
|
Loss
ratio
|
0.0
%
|
0
%*
|
|
Acquisition
cost ratio
|
11.0
%
|
0
%*
|
|
Expense
ratio
|
104.2
%
|
0
%*
|
|
Combined
ratio
|
104.2
%
|
0
%*
|
|
*Ratios
reflected as 0.0% due to no "net premiums earned" during the
period.
|
|
|
|
Exhibit No.
|
|
Document
|
|
|
|
|
|
|
Certifications
of the Chief Executive Officer pursuant to Section 302 of the
Sarbanes-Oxley Act and Rule 13a-14(a) or 15d-14(a) under the
Securities Exchange Act of 1934.
|
|
|
|
|
|
|
|
Certifications
of the Chief Financial Officer pursuant to Section 302 of the
Sarbanes-Oxley Act and Rule 13a-14(a) or 15d-14(a) under the
Securities Exchange Act of 1934.
|
|
|
|
|
|
|
|
Written
Statement of the Chief Executive Officer and Chief Financial
Officer pursuant to 18 U.S.C. §1350.
|
|
|
|
|
|
|
101
|
|
The
following materials from Oxbridge Re Holdings Limited’s
Quarterly Report on Form 10-Q for the quarter ended March 31, 2020
are filed herewith, formatted in XBRL (Extensible Business
Reporting Language): (i) the Consolidated Balance Sheets, (ii) the
Consolidated Statements of Operations, (iii) the Consolidated
Statements of Comprehensive Income, (iv) the Consolidated
Statements of Cash Flows, (v) the Consolidated Statements of
Changes in Shareholders’ Equity and (vi) the Notes to
Consolidated Financial Statements.
|
|
|
OXBRIDGE
RE HOLDINGS LIMITED
|
|
|
|
|
Date:
May 14, 2020
|
By: /s/
JAY
MADHU
|
|
|
Jay
MadhuChief Executive Officer and President(Principal Executive
Officer)
|
|
|
|
|
Date:
May 14, 2020
|
By: /s/
WRENDON
TIMOTHY
|
|
|
Wrendon
TimothyChief Financial Officer and Secretary(Principal Financial
Officer and PrincipalAccounting Officer)
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|